{"id":10780,"date":"2019-11-14T17:34:43","date_gmt":"2019-11-14T16:34:43","guid":{"rendered":"https:\/\/udic.es\/?p=10780"},"modified":"2019-11-29T09:37:30","modified_gmt":"2019-11-29T08:37:30","slug":"subcutaneous-levodopa-infusion-pump-in-advanced-parkinson","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/","title":{"rendered":"Subcutaneous levodopa infusion pump in advanced Parkinson"},"content":{"rendered":"

The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor fluctuations in advanced Parkinson’s isease. It will compare with standard Levodopa in a double-blind study. Up to now this has not been possible due to high volume required. This \u201cultra concentrated\u201d levodopa allows its subcutaneous administration, for an adequate control of the motor blockages that cause so much suffering to the patients. It is intended to improve their quality of life. In January 2020 the investigators meeting will be held in Barcelona.<\/p>\n","protected":false},"excerpt":{"rendered":"

The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor fluctuations in advanced Parkinson’s isease. It will compare with standard Levodopa in a double-blind study. Up to now this has not been possible due to high volume required. This \u201cultra concentrated\u201d levodopa…<\/p>\n","protected":false},"author":4,"featured_media":9273,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"class_list":["post-10780","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-parkinson-en"],"yoast_head":"\nSubcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Subcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-14T16:34:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-29T08:37:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"5056\" \/>\n\t<meta property=\"og:image:height\" content=\"1752\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"SUSANA ANDRADE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SUSANA ANDRADE\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\"},\"author\":{\"name\":\"SUSANA ANDRADE\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\"},\"headline\":\"Subcutaneous levodopa infusion pump in advanced Parkinson\",\"datePublished\":\"2019-11-14T16:34:43+00:00\",\"dateModified\":\"2019-11-29T08:37:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\"},\"wordCount\":101,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"articleSection\":[\"Parkinson\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\",\"url\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\",\"name\":\"Subcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"datePublished\":\"2019-11-14T16:34:43+00:00\",\"dateModified\":\"2019-11-29T08:37:30+00:00\",\"description\":\"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg\",\"width\":5056,\"height\":1752,\"caption\":\"Udichome3\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Subcutaneous levodopa infusion pump in advanced Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\",\"name\":\"SUSANA ANDRADE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"caption\":\"SUSANA ANDRADE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Subcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/","og_locale":"en_US","og_type":"article","og_title":"Subcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","og_description":"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor","og_url":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/","og_site_name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2019-11-14T16:34:43+00:00","article_modified_time":"2019-11-29T08:37:30+00:00","og_image":[{"width":5056,"height":1752,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","type":"image\/jpeg"}],"author":"SUSANA ANDRADE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SUSANA ANDRADE"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#article","isPartOf":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/"},"author":{"name":"SUSANA ANDRADE","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03"},"headline":"Subcutaneous levodopa infusion pump in advanced Parkinson","datePublished":"2019-11-14T16:34:43+00:00","dateModified":"2019-11-29T08:37:30+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/"},"wordCount":101,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","articleSection":["Parkinson"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/","url":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/","name":"Subcutaneous levodopa infusion pump in advanced Parkinson - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","datePublished":"2019-11-14T16:34:43+00:00","dateModified":"2019-11-29T08:37:30+00:00","description":"The UDIC will start a new clinical trial that evaluates the subcutaneous administration of levodopa, using a continuous perfusion pump, to treat motor","breadcrumb":{"@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/Udichome3.jpg","width":5056,"height":1752,"caption":"Udichome3"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"Subcutaneous levodopa infusion pump in advanced Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"Unitat D'Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03","name":"SUSANA ANDRADE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","caption":"SUSANA ANDRADE"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=10780"}],"version-history":[{"count":0,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10780\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media\/9273"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=10780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/categories?post=10780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/tags?post=10780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}